The medical communications agency helping clients launch, build and develop great pharmaceutical brands.

As a full-service agency, we use Pharmacohesion® to help you to refine your strategic thinking across all channels, using marketing and scientific insight. From creative execution to rigorous measurement, we ensure your brand makes an impact.

What is PharmaCohesion®?

In trusted partnerships with…

“We want to help your brands fulfil the ambitions of the scientists who developed them: to transform the lives of patients with an unmet medical need.”

Matthew Dickinson, Managing Director

meet the team

Your brands were developed to meet a medical need. We help you make sure your dream is fulfilled.

Improving lives, saving lives

Pharmacohesion® ensures that healthcare professionals understand why your brand exists, know how it fits into their treatment paradigm, and can access it to treat their patients in need.

Nurturing relationships

KOLs, prescribers, payors and patients all need to feel that you are working in their best interests, that they are more to you than just a commercial transaction. We craft your communications with all stakeholders so they know you are their partners in therapeutic problem-solving.

Delivering results

Through Pharmacohesion® – our rigorous process of analysis, strategic thinking, tactical creativity and precise execution – we deliver communications that allow all your customer-facing teams to make an impression, convey your brand and company values, and engender long-term loyalty.

Learn more about us

Alea

A new quarterly that’s a result of our whole team’s collaboration and insight.

Each edition of Alea will offer an array of content from members of the Dice team as well as occasional contributions from industry big-hitters. However, the last thing we want to do is bombard clients who already spend their days buried in medical reports. For that reason, we’ve made sure to mix it up, combining industry insight and analysis with interviews and imagery that stirs the emotions.

Subscribe below to get the latest insights straight to your inbox.